Avanzi MP, Goldberg F, Davila J et al (2014) Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulation. Br J Haematol 164:867–876

Article  CAS  PubMed  Google Scholar 

Boyle ST, Poltavets V, Kular J et al (2020) ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism. Nat Cell Biol 22:882–895

Article  CAS  PubMed  Google Scholar 

De Rooij JDE, Branstetter C, Ma J et al (2017) Pediatric non-down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. Nat Genet 49:451

Article  PubMed  PubMed Central  Google Scholar 

Du R, Huang C, Liu K et al (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for Cancer therapy. Mol Cancer 20:15

Gangat N, Marinaccio C, Swords R et al (2019) Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: a phase I trial. Clin Cancer Res 25:4898–4906

Article  CAS  PubMed  Google Scholar 

Gruber TA, Downing JR (2015) The biology of pediatric acute megakaryoblastic leukemia. Blood 126:943–949

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gruber TA, Larson Gedman A, Zhang J et al (2012) An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell 22:683–697

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hama A, Taga T, Tomizawa D et al (2023) Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome. Br J Haematol. https://doi.org/10.1111/BJH.18691

Article  PubMed  Google Scholar 

Kümper S, Mardakheh FK, McCarthy A et al (2016) Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis. Elife 5, e12994

Lo Coco G, Lo Coco D, Cicero V et al (2005) Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers. J Neurol Sci 238:11–17

Article  PubMed  Google Scholar 

Lordier L, Jalil A, Aurade F et al (2008) Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood 112:3164–3174

Article  CAS  PubMed  Google Scholar 

Lordier L, Bluteau D, Jalil A et al (2012) RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun 3:717

Mali RS, Ramdas B, Ma P et al (2011) Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3 and BCR-ABL. Cancer Cell 20:357

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malinge S, Izraeli S, Crispino JD (2009) Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 113:2619–2628

Article  CAS  PubMed  PubMed Central  Google Scholar 

McNulty M, Crispino JD (2020) Acute megakaryocytic leukemia. Cold Spring Harb Perspect Med 10:a034884

Pang L, Weiss MJ, Poncz M (2005) Megakaryocyte biology and related disorders. J Clin Invest 115:3332

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi K, Hu X, Yu X et al (2022) Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia. Leuk Res 120:106920

Sabnis N, Lacko AG (2012) Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics. Ther Deliv 3:599–608

Article  CAS  PubMed  Google Scholar 

Saultier P, Cabantous S, Puceat M et al (2021) GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis. J Thromb Haemost 19:2287–2301

Article  CAS  PubMed  Google Scholar 

Shibuya M, Suzuki Y, Sugita K et al (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571–577

Article  CAS  PubMed  Google Scholar 

Vennin C, Chin VT, Warren SC et al (2017) Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Sci Transl Med 9:eaai8504

Wechsler J, Greene M, McDevitt MA et al (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 32:148–152

Article  CAS  PubMed  Google Scholar 

Wen Q, Goldenson B, Silver SJ et al (2012) Integrative screening approach identifies regulators of polyploidization and targets for acute megakaryocytic leukemia. Cell 150:575

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wermke M, Camgoz A, Paszkowski-Rogacz M et al (2015) RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug. Blood 125:3760–3768

Article  CAS  PubMed  Google Scholar 

Yang Q, Crispino JD, Wen QJ (2016) Kinase signaling and targeted therapy for primary myelofibrosis. Exp Hematol 48:32–38

Article  PubMed  PubMed Central  Google Scholar